Merit's transradial Prelude sheath:
This article was originally published in Clinica
The US FDA has given Merit Medical Systems 510(k) market clearance to use its Prelude sheath introducer system in transradial catheterisation applications. "In many European, South American and Asian markets, this access method accounts for the majority of procedures," the South Jordan, Utah firm's chairman and CEO, Fred Lampropoulos, said of the transradial indication.
You may also be interested in...
C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.
ChromaDex is among latest targets of FDA/FTC joint warnings identifying claims on websites as well as in social media posts that render products unapproved and misbranded drugs indicated to prevent or treat COVID-19.
A senior executive shares insights around how the global logistics provider is preparing to deliver the upcoming COVID-19 vaccines across the world. While the company has prior experience with the "deep frozen" temperatures needed for some candidates, there will still be specific challenges and complexities involved.